Acromegaly [overproduction of GH (growth hormone)] is associated with cardiovascular disease. Transgenic mice overexpressing bGH (bovine GH) develop hypertension and hypercholesterolaemia and could be a model for cardiovascular disease in acromegaly. The aims of the present study were to investigate the effects of excess GH on vascular function and to test whether oxidative stress affects endothelial function in bGH transgenic mice. We studied the ACh (acetylcholine)-induced relaxation response in aortic and carotid rings of young (9-11 weeks) and aged (22-24 weeks) female bGH transgenic mice and littermate control mice, without and with the addition of a free radical scavenger {MnTBAP [Mn(III)tetrakis(4-benzoic acid)porphyrin chloride]}. We also measured mRNA levels of eNOS (endothelial nitric oxide synthase) and EC-SOD (extracellular superoxide dismutase). Intracellular superoxide anion production in the vascular wall was estimated using a dihydroethidium probe. Carotid arteries from bGH transgenic mice had an impaired ACh-induced relaxation response (young, 46 + − 7 % compared with 69 + − 8 %; aged, 52 + − 5 % compared with 80 + − 3 %; P < 0.05), whereas endothelial function in aorta was intact in young but impaired in aged bGH transgenic mice. Endothelial dysfunction was corrected by addition of MnTBAP in carotid arteries from young mice and in aortas from aged mice; however, MnTBAP did not correct endothelial dysfunction in carotid arteries from aged bGH transgenic mice. There was no difference in intracellular superoxide anion production between bGH transgenic mice and control mice, whereas mRNA expression of EC-SOD and eNOS was increased in aortas from young bGH transgenic mice compared with control mice (P < 0.05). We interpret these data to suggest that bGH overexpression is associated with a time-and vesselspecific deterioration in endothelial function, initially caused by increased oxidative stress and later by other alterations in vascular function.
INTRODUCTION
Acromegaly, characterized by excessive secretion of GH (growth hormone), is associated with cardiovascular disease [1] . Indeed, cardiovascular events are the most common cause of death in acromegalic patients [2, 3] . However, the long-term effects of excess GH and IGF-I (insulin-like growth factor-I) on vascular function have been only sparsely evaluated. Further studies are needed to shed light on the effects of excess GH on the development of vascular disease.
The transgenic mouse overexpressing bGH (bovine GH) is a possible model of human acromegaly. bGH transgenic mice share many of the common complications of human acromegalic patients, such as hypertension [4] and high levels of serum cholesterol and hyperinsulinaemia, without the characteristics of the metabolic syndrome [5] . It is well known that these disorders are associated with endothelial dysfunction [6] [7] [8] , an early marker for atherosclerosis. Despite the presence of these risk factors, we have shown previously [4] that endothelial function of the resistance vessels of bGH transgenic mice remains intact. However, endothelial function of larger arteries, i.e. conduit vessels, which are more susceptible to developing atherosclerosis than mesenteric arteries, has until now not been studied in this mouse model.
Endothelial function involves a finely tuned balance between vasoactive factors acting to dilate or constrict the vessel. Endothelial dysfunction, an imbalance between dilator and constrictor agents, could result from increased production of ROS (reactive oxygen species) [9] . Several studies have shown that hyperinsulinaemia and hypercholesterolaemia, which are both present in bGH transgenic mice, generate oxidative stress and may result in endothelial dysfunction [10, 11] . To test whether oxidative stress may affect large conduit artery endothelial function in bGH transgenic mice we studied ex vivo vascular function without and with the addition of MnTBAP [Mn(III)tetrakis(4-benzoic acid)porphyrin chloride], an SOD (superoxide dismutase) mimetic and peroxynitrite scavenger. We also measured mRNA levels of eNOS and iNOS [endothelial and inducible NO (nitric oxide) synthase respectively], EC (extracellular)-SOD, caveolin-1 and ET-1 (endothelin-1), as these factors are thought to be involved in the control of endothelial function. Young (9-11 weeks) and aged (22-24 weeks) mice were studied. To study the mechanisms behind endothelial dysfunction further, we measured whole-body NO formation rate as well as intracellular O 2 − (superoxide anion) production in the vascular wall.
METHODS

Animals
Transgenic mice overexpressing bGH were generated as described previously [4] . This strain typically have elevated serum bGH (1000-1400 ng/ml in female mice) and IGF-I levels (700-770 ng/ml) [12] compared with approx. 10 ng/ml endogenous mouse GH [13] and 300-480 ng/ml IGF-I in wild-type mice [12] . See Table 3 for the body weights of the mice used in the study. Female bGH transgenic and littermate control mice were used in all experiments, and two age groups were studied: 9-11 and 22-24 weeks of age, referred to as 'young' and 'aged' respectively. The age of the mice was chosen considering that bGH transgenic mice have a tendency to develop liver tumours when they reach an age of approx. 7-8 months (M. Bohlooly-Y, unpublished work). However, macroscopic tumours were not present in any mouse in the present study. All mice were housed at a constant temperature (20 
Ex vivo vascular function
Ex vivo vascular function was investigated in carotid arteries and aortas from bGH transgenic (young, n = 7; aged, n = 10) and control (young, n = 7; aged, n = 10) mice. The mice were given an overdose of pentobarbital sodium (Apoteksbolaget) and rings of left common carotid artery and thoracic aorta (approx. 3 mm) were dissected out and kept in PSS (physiological salt solution; 119 mmol/l NaCl, 25 mmol/l NaHCO 3 , 11 mmol/l glucose, 4.7 mmol/l KCl, 2.5 mmol/l CaCl 2 , 1.2 mmol/l KH 2 PO 4 , 1.2 mmol/l MgSO 4 and 0.027 mmol/l EDTA). Insulin (9 nmol/l; ACTRA-PID ® ; Novo Nordisk) was added to the solution to match the increased insulin levels in bGH transgenic mice [14] . A pilot study on a total of four vessels (two aortas and two carotid arteries) demonstrated that this concentration of insulin did not affect either resting tension or amplitude of contraction to NE (noradrenaline) and KCl. Two doses of NE (10 µmol/l) and one dose of KCl were applied to each vessel at different time points. The contractile response to NE of the vessels with insulin (9 nmol/l) was not different from the response of those without insulin (101 + − 15 % of control). The corresponding value for KCl response was 94 + − 15 %. Furthermore, the relaxation response to ACh (acetylcholine) did not differ between the groups (results not shown).
The segments were mounted in a Multimyograph 610M (Danish Myo Technology) and the protocol proceeded as described below. The remaining aorta was cleaned of fat and connective tissue, snap frozen in liquid nitrogen and stored at − 70
• C for later analyses. The aortic rings were stretched to 2 mN and equilibrated for 30 min. Due to the larger body size of bGH transgenic mice, the vessel wall and lumen size was also larger. This could possibly affect the outcome of the functional studies, and therefore effort was made to normalize the starting conditions of the vessel, as described below. Before starting the pharmacological protocol, the aortas were stretched further to 10 mN and allowed to stabilize. The carotid arteries were normalized by stepwise extension according to the manufacturer's protocol, so that the isometric wall tension was recorded at well defined internal circumferences. The solutions used were equilibrated with 5 % CO 2 and bath temperatures maintained at 37
• C. Before the onset of the experiment, the vessel strips were activated by 100 mmol/l KCl, 10 µmol/l NE (arterenol; Sigma) and finally 100 mmol/l KCl with a 5 min wash-out in between. The endotheliumdependent relaxation response was studied by cumulative concentration-response to ACh (0.03-6 µmol/l) on vessels contracted 50-100 % of maximal contraction to NE. ACh was applied in the control situation after 30 min of incubation with 10 µmol/l MnTBAP (Calbiochem), and after 30 min of incubation with the NOS inhibitor l-NNA (N G -nitro-l-arginine; 100 µmol/l; Sigma). Two doses of SNP (sodium nitroprusside; 10 and 100 µmol/l; Sigma) were applied after each ACh concentration response to validate endothelium-independent relaxation. Due to technical difficulties, one aorta from a young control mouse and one carotid artery from an aged bGH transgenic mouse were excluded from the study.
Quantification of gene expression in aortic tissue
Intact aortic tissue was collected from bGH transgenic (young, n = 9; aged, n = 7) and control (young, n = 9; aged, n = 9) mice. RNA was extracted using Trizol ® -Reagent (Life Technologies), according to the manufacturer's protocol, and measured by Ribogreen (Molecular Probes) using the SPECTRA max Gemini microplate reader (Molecular Devices) and registered digitally by Soft Max PRO 3.1 (Molecular Devices). RT (reverse transcription) was carried out using Thermoscript TM RT-PCR system (Invitrogen) according to the manufacturer's protocol. A portion (0.3 µg) of total RNA was used in a total volume of 20 µl. Samples were incubated at 25
• C for 10 min, at 50
• C for 50 min and at 85
• C for 5 min on a Corbett Thermocycler (Corbett Research). Relative quantification of mRNA expression was performed on a LightCycler (Roche Diagnostics) using SYBR ® green I. For amplification of eNOS, iNOS, ET-1, caveolin-1 and EC-SOD, 2 µl of cDNA diluted 1:8 was added to FastStart Master SYBR ® green I (Roche Diagnostics) and forward (0.5 µmol/l) and reverse primers (0.5 µmol/l) in a final volume of 20 µl. GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was selected as an endogenous control to correct for potential variation in RNA loading or efficiency of the amplification reaction. cDNA was added to a reaction mixture consisting of 1 × PCR buffer (Sigma), 5 mmol/l MgCl 2 (Sigma), 0.2 mmol/l dNTP, 0.1 g/l BSA (Fermentas), 1 unit of Taq DNA polymerase (Sigma), 0.5 × SYBR ® green I, 0.3 µmol/l forward primer and 0.5 µmol/l reverse primer. Thermal cycling conditions included denaturing followed by approx. 50 amplification cycles as shown in Table 1 . Finally, samples were cooled to 35
• C for 30 s. One sample from each run served as an internal control in the subsequent run. Oligonucleotide primers for GAPDH were designed using Primer Express version 1.0 (PerkinElmer Applied Biosystems). For the genes analysed, LightCycler Probe Design Software version 1.0 (Roche Diagnostics) was used to design primers (Table 2) . A standard curve was obtained by 2-fold serial template dilutions of cDNA (from 1:2-1:32 for each gene). The initial amount (IA) was determined using the equation: IA = Cp-b/m, where Cp is the virtual cycle number at which the total fluorescence signal increases at maximum acceleration, b is the y-axis intercept and m is the slope of the individual standard curve [15] . Relative expression level of the target gene is expressed as a ratio between target and GAPDH cDNA.
Detection of O 2
− in aorta and carotid artery DHE (dihydroethidium; Molecular Probes) was used to visualize O 2 − in aortas and carotid arteries. DHE is a cellpermeant dye which, in the presence of O 2 − , is oxidized to the red fluorescent compound ethidium. Ethidium intercalates with double-stranded DNA and thus gets trapped in the cell [16] . Vessels were collected from bGH transgenic (young, n = 2; and aged, n = 3) and littermate control (young, n = 4; and aged, n = 3) mice after an overdose of inhaled anaesthesia (isoflurane; Baxter Healthcare). Tissue was embedded in OCT compound and frozen in liquid N 2 . Sections (30 µm thick) were stained with DHE (5 µmol/l in Tyrode buffer), with particular attention paid to parallel and similar treatment of the sections. Images were collected using a laser scanning confocal microscope (Zeiss LSM 510 META system) with an excitation wavelength of 488 nm and an emission wavelength of 610 nm. Micro Image 4.0 for Windows (Olympus Optical) was used to trace the outline of the vessels and DHE-stained areas. The fraction of DHE-stained areas was calculated by dividing the sum of the stained areas with the total cross-sectional area of the vessel.
Immunohistochemistry
Immunohistochemistry was performed on frozen OCTembedded acetone-fixed sections of aorta from the same mice used for DHE detection. Sections were hydrated in PBS for 30 min, endogenous peroxidase was blocked by 3 % (v/v) H 2 O 2 and biotin was blocked by avidin/biotin blocking kit (Vector Laboratories). Sections were stained with anti-eNOS (1:50 dilution; #610296), anti-iNOS (1:200 dilution; #610328) or anti-caveolin-1 (1:200 dilution; #610057; DB Biosciences Pharmingen) antibodies, together with the M.O.M kit (Vector Laboratories) to reduce background staining. Sections were also stained with an anti-EC-SOD antibody (1:10 000 dilution), followed by goat anti-rabbit secondary antibody (1:200 dilution; Vector Laboratories). Sections were stained with Texas Red or DAB (diaminobenzidine). As control for non-specific binding, primary antibodies were replaced with diluents.
NO formation rate
The absolute whole-body formation rate of NO in vivo can be calculated from the appearance rate of nitrate residues with various number of 18 O 2 atoms incorporated into nitrate residues during 18 O 2 inhalation. NO formation rate was measured in young and aged bGH transgenic and control mice (n = 6). A young bGH mouse was excluded due to possible infection. The procedure for evaluation of NO formation rate in mice has been described in detail previously [17] . In brief, mice were pairwise exposed to a gas mixture containing 18 O 2 (> 97 % isotope purity; Larodan Fine Chemicals), 16 O 2 and air for 2 h in a closed gas-tight cage system. Gas samples for determination of 18 O 2 , 16 O 2 , CO 2 and N 2 from the cage system were taken every 10 min and immediately analysed in a Varian Saturn ion-trap mass spectrometer operated in the electron ionization mode. During isoflurane anaesthesia, a 200 µl sample of whole blood was collected from the orbital vein directly before (< 5 min) and after gas exposure. Plasma collected in EDTA was frozen for later analysis of newly formed 18 O 2 -labelled nitrate by GC/MS [17] . Calculations of total-body NO formation rate (µmol · h −1 · kg −1 of body weight) were performed as described previously [17] .
Statistics
All data are expressed as means + − S.E.M. Prism TM 3.0 (GraphPad) was used to analyse the ACh concentrationresponse relationships using the AUC (area under curve) algorithm. AUC and other groups of data were assessed with an unpaired Student t test. A value of P < 0.05 was considered to be statistically significant.
RESULTS
Contractile response
The maximal contraction in response to KCl and NE did not differ between vessels from bGH transgenic and control mice, except for aortas from aged bGH transgenic mice which showed reduced contraction compared with aortas from control mice (KCl, 73 + − 5 %; and NE, 77 + − 4 %; P < 0.05 for both). These findings suggest that maximal non-specific contractile properties of the vascular wall are similar in young bGH transgenic and control mice, but somewhat reduced in aortas from aged bGH transgenic mice.
Endothelial function of young mice
The maximal relaxation response to ACh was impaired in carotid arteries from young bGH transgenic mice compared with control mice (46 + − 7 % in bGH transgenic mice compared with 69 + − 8 % in control mice; P < 0.05; Figure 1A ). Incubation with MnTBAP abolished this difference (52 + − 10 % in bGH transgenic mice compared with 62 + − 11 % in control mice; Figure 1B) . Exposure of carotid arteries to the combination of MnTBAP and l-NNA completely abolished the vasodilator response to ACh ( Figure 1B) ; however, in the aorta, there was no difference in the maximal response to ACh between bGH transgenic and control mice (68 + − 10 % in bGH transgenic mice compared with 69 + − 6 % in control mice; Figure 1C ). Similarly, there was no difference in the response following MnTBAP ( Figure 1D ). Exposure to the combination of both MnTBAP and l-NNA caused a reduction but did not completely prevent the relaxation response in the aortas ( Figure 1D ). 
Endothelial function of aged mice
The relaxation response to ACh in carotid arteries from aged bGH transgenic mice was impaired (P < 0.05; Figure 2A ). However, in contrast with young mice, the reduced relaxation response was not corrected by incubation with MnTBAP ( Figure 2B ). Addition of l-NNA reversed the relaxation towards constriction, which was indistinguishable between the groups ( Figure 2B ). In contrast with young bGH transgenic mice, the aorta from aged bGH transgenic mice had an impaired relaxation response to ACh compared with control mice (P < 0.05; Figure 2C ). Incubation with MnTBAP abolished this difference (66 + − 4 % in bGH transgenic mice compared with 71 + − 6 % in control mice), whereas l-NNA was equally effective in preventing relaxation in both groups (Figure 2D) .
Effect of SNP
SNP was added to all preparations at the end of individual concentration-response curves. The maximal SNP-induced endothelium-independent dilation was profound in all vessels and indistinguishable between the groups (82-110 %). This finding suggests an intact smooth muscle cell function in all preparations and that the differences observed above for ACh were endothelium dependent.
Quantification of gene expression in aortic tissue
Standard curves for the six genes were obtained by plotting log dilution (x-axis) against Cp values (y-axis).
The correlation factor for linear regression analysis for the genes was between 0.98 and 1.0. Amplification efficiencies expressed as the slope of the standard curves did not differ between the genes. The standard curves were used to calculate the relative dilution value of each unknown sample. The calculated relative dilution values for GAPDH, obtained by a second derivative maximum method, were similar in experimental and control groups (results not shown). iNOS mRNA was not detected in any of the samples. No difference in the expression of caveolin-1 mRNA was seen when young bGH transgenic and control mice were compared (2.4 + − 0.2 compared with 3.0 + − 0.3 arbitrary units respectively) or when aged bGH transgenic and control mice were compared (1.7 + − 0.5 compared with 2.4 + − 0.6 arbitrary units respectively). Similarly, no differences in expression of ET-1 were detected between young bGH transgenic and control mice (1.0 + − 0.1 compared with 1.3 + − 0.2 arbitrary units respectively) or aged bGH transgenic and control mice (0.9 + − 0.2 compared with 1.2 + − 0.4 arbitrary units respectively).
EC-SOD mRNA expression was increased by 76 + − 23 % in young bGH transgenic mice compared with control mice (P < 0.05; Figure 3A) . eNOS expression was increased by 62 + − 15 % in young bGH transgenic mice compared with control mice (P < 0.05; Figure 3B ). No differences in gene expression were found between aged bGH transgenic mice and control mice.
Detection of O 2
− production in aorta and carotid arteries Intracellular O 2 − production was detected throughout the vessel walls of aorta and carotid arteries; however, there were no differences between bGH transgenic and control mice (Table 3) .
Immunohistochemistry
Expression of eNOS protein in the intima of both aorta and carotid artery of bGH transgenic mice and control mice was detected by qualitative immunohistochemistry. 
Production of NO
No differences in whole-body NO formation rate were detected between bGH transgenic and control mice (Table 3) .
DISCUSSION
Overexpression of GH in man is associated with insulin resistance (30-45 %), hypertension (20-40 %) and dyslipidaemia [18, 19] . These are all risk factors for development of atherosclerosis and are all associated with endothelial dysfunction [6] [7] [8] . Transgenic mice overexpressing bGH are hypertensive [4] , have high levels of serum LDL (low-density lipoprotein)-cholesterol and 
Figure 4 Aortic localization of eNOS (A and B) and EC-SOD protein expression (C and D) in young control (A and C) and bGH transgenic (B and D) mice
The arrows indicate specifically stained areas. Sections were stained with Texas Red (A and B) and DAB (C and D). Scale bar, 50 µm.
insulin [5] . Despite the presence of these risk factors for atherosclerosis, we have shown previously [4] intact endothelial function of mesenteric arteries in bGH transgenic mice. This was surprising and therefore, in the present study, we investigated the effects of excess GH on endothelial function of conduit vessels, the aorta and common carotid artery, which are prone to developing atherosclerotic disease. In the present study, it was found that endothelial function in bGH transgenic mice deteriorated and that the carotid artery is affected earlier than the aorta. The dilatory response of the carotid artery in young bGH transgenic mice could be normalized to the level in control mice by incubation with the SOD mimetic and peroxynitrite scavenger MnTBAP. Interestingly, the impaired relaxation response in the carotid artery of aged bGH transgenic mice was not affected by MnTBAP. In contrast, the aortic relaxation response to ACh was intact in young bGH transgenic mice, although an MnTBAP-sensitive impairment of vasodilator capacity was observed in the aorta of aged bGH transgenic mice. Our interpretation of these results is that there is a vesseland time-specific deterioration of endothelial function in bGH transgenic mice. The carotid artery is affected first and the aorta follows after a few months of exposure to elevated bGH. The addition of l-NNA completely suppressed the ACh-induced dilation in the carotid artery as well as the major portion of the dilator response in the aorta, suggesting that NO is the principal mediator of the ACh-evoked response in both bGH transgenic and control mice. This finding suggests only a minor role for other dilatory substances, such as EDHF (endothelium-derived hyperpolarizing factor) or prostaglandins.
One of the known mechanisms behind impaired endothelial function is increased production of the free radical O 2 − , which rapidly reacts with NO to form peroxynitrite. Excess O 2 − production, if not scavenged, may thus decrease NO availability [9] . Furthermore, peroxynitrite is a proposed mediator of vascular tissue injury that ultimately may result in atherosclerosis [20] . Restoration of endothelial function in carotid arteries of young bGH transgenic mice and aortas of aged bGH transgenic mice after incubation with MnTBAP therefore suggests that the origin of the early phase of endothelial dysfunction in bGH transgenic mice is an imbalance between antioxidant defence and O 2 − production. However, endothelial dysfunction observed in the carotid artery of aged bGH transgenic mice was not corrected by antioxidant treatment, which suggests that it is caused by structural or functional divergences in the vessel wall other than decreased NO availability due to increased oxidative stress. It has been proposed that intimal thickening in atherosclerosis may add to the observed endothelial dysfunction by increasing the diffusion distance for NO from the endothelium to smooth muscle cells [21] . This question was not addressed in the present study, but it is possible that the long-term growth-stimulating effects of GH result in intimal thickening, which may explain at least part of the endothelial dysfunction found in carotid arteries of aged bGH transgenic mice. Indeed, intimal thickening has been described in acromegalic patients [22] .
In additional experiments we attempted to dissect out the more precise mechanisms behind the observed functional oxidative stress/defence imbalance. First, we analysed mRNA levels of key enzymes in regulation of endothelial function. Unfortunately, this could only be reliably done on aortic tissue, due to the very limited amount of mRNA from carotid arteries. Interestingly, we found that aortic mRNA levels of EC-SOD were increased specifically in aorta from young bGH transgenic mice compared with control mice. The exact role of EC-SOD in oxidative stress is not fully known [23] but, because of its main location between endothelial and smooth muscle cells, it has been hailed as the principal regulator of NO bioavailability [24] . Increased EC-SOD mRNA expression might thus act to increase NO bioavailability in aorta from young bGH transgenic mice. As stated previously [9] , intact endothelial function requires a finely tuned balance between the production of ROS and antioxidant defence. To this end, we also observed increased eNOS mRNA expression in aorta from young bGH transgenic mice, which might contribute further to the formation of NO. In this context, it is important to note that up-regulated mRNA does not necessarily signify increased protein levels, and a limitation of the present study is the lack of protein quantification. However, eNOS as well as EC-SOD protein was readily identified in the aorta and carotid artery of bGH transgenic mice by immunohistochemical staining. Taken together, these results provide an explanation for the intact endothelial function of aorta from young bGH transgenic mice.
However, the results mentioned above do not explain the mechanisms behind the impaired endothelial function in bGH transgenic mice. We speculated that the distortion may be towards a higher production of ROS, rather than reduced antioxidant defence. Therefore we measured the production of ROS. DHE staining was used to semi-quantify production of intracellular O 2 − , but no difference between the bGH transgenic and control mice was detected. The DHE probe is considered specific for O 2 − , but does only provide an approximate estimation of superoxide production [25] and, in addition, it does not take into account extracellular production of ROS.
We also applied a newly developed technique to measure NO formation in mice [17] . By exposing animals to a known concentration of 18 O 2 -labelled gas, the rate of whole-animal NO formation could be calculated. No differences in the production of NO were detected between the groups. This suggests that the mechanism for endothelial dysfunction in bGH transgenic mice is decreased NO availability, rather than reduced NO formation. However, even though the technique has been validated as a specific method for detection of changes in NO production in mice, it does not allow discrimination between different organs or vascular beds [17] . Thus there might be local up-or down-regulation of NO production in the different vascular beds that can only be detected by local NO measurements. This discrepancy is highlighted by the observed increase in eNOS mRNA expression in aortic tissue.
The complexity of vascular biology sometimes makes it difficult to draw firm conclusions from individually up-or down-regulated factors. We strongly believe that functional tests on intact vessels yield the most appropriate understanding of vascular/endothelial function. Based on this, we suggest that endothelial dysfunction in bGH transgenic mice initially is caused by an increased oxidative stress and/or a decreased oxidative defence. What might be the mechanisms? In the literature, we have found no support for GH to stimulate oxidative stress directly. However, bGH transgenic mice develop hyperinsulinaemia and hypercholesterolaemia [5] . As both these conditions are associated with increased oxidative stress [10, 11] , this might be the mechanism behind the observed endothelial dysfunction.
Endothelial dysfunction of the carotid artery was observed in young bGH transgenic mice, whereas aortic endothelial function was still intact. It is intriguing to speculate as to why the aorta and carotid artery apparently deteriorate with different time constants. One possibility is that the vascular defence against oxidative stress (in this case EC-SOD and eNOS) is not so well developed in the carotid artery compared with the aorta and, thus, endothelial dysfunction develops earlier in this vascular segment. Another possibility is that the carotid artery in general is more prone to develop endothelial dysfunction due to other factors such as vascular flow profiles or other differences in the local environment. Differences due to location and local environment are supported by the previous finding that resistance vessels from aged bGH transgenic and control mice have intact endothelial function [4] .
In conclusion, bGH transgenic mice develop endothelial dysfunction in both the carotid artery and aorta. However, the deterioration seems to proceed with different time constants in the different vessels and appears to be initiated due to an imbalance between production of ROS and antioxidant defence. However, in a later phase, structural alterations in vascular function may be responsible for the endothelial dysfunction.
